1. In Vivo
  2. >>Leadership

Direct To Consumer Approach Underscores Femtech’s Disruptive Potential

New Accelerator Looks To Fill Information Gaps About Femtech Market And Support Start-Ups

 
• By Lucie Ellis-Taitt

A new technology accelerator, FemTech Lab, will support the scale-up of at least 10 firms in 2021 that have innovative solutions for issues affecting women’s health and wellbeing. The founders talk to In Vivo about their view of the femtech market and how it will impact traditional health care.

lightbulbs

The first of its kind in Europe, FemTech Lab launched in London at the end of 2020 as a new accelerator to help femtech entrepreneurs get their companies investment ready. It offers a 3-month program – enrolling 10 start-ups in the first cohort – to assist new companies in getting their products to market. During the program, the start-ups have access to world-class experts and resources to scale their product development, they can utilize relevant go-to-market channels, and receive advice on how to raise the necessary funds to get from innovative idea to fully fledged company.

Alongside business growth, FemTech Lab helps start-up founders to grow as leaders – addressing a talent gap in the European...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Leadership

Wealth Of MedTech Innovator Asia Pacific Entries Underlines Rising Caliber Of Local Technologies

 
• By Ashley Yeo

The culmination of the MedTech Innovator APAC awards program 2025 comes later this month when the top prizes are handed out at the grand final in Singapore. But all cohort companies benefit from the competition’s mentoring process, says awards organizer Fredrik Nyberg.

Execs On The Move: September 2025

 
• By In Vivo Team

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

One Year In, Xaira’s Drug Discovery Vision Meets Reality

 
• By David Wild

The billion-dollar startup has doubled headcount, released massive datasets and is advancing therapeutics, but the hard part lies ahead.

Podcast: Essential Pharma – Following A Patient First Philosophy 

Essential Pharma CEO Emma Johnson discusses the company’s strategic priorities and plans for growth as it expands its portfolio in rare diseases.

More from In Vivo

China’s Medtech Policies Prompt Reflection Among Global Companies As Local Players Adapt

 
• By Ashley Yeo

Chinese medtechs are expanding rapidly worldwide, but gaining market access within China itself – poised to become the world’s largest medtech market – is proving to be a very different challenge.

Execs On The Move: September 2025

 
• By In Vivo Team

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

One Year In, Xaira’s Drug Discovery Vision Meets Reality

 
• By David Wild

The billion-dollar startup has doubled headcount, released massive datasets and is advancing therapeutics, but the hard part lies ahead.